G protein βγ translocation to the Golgi apparatus activates MAPK via p110γ-p101 heterodimers

被引:12
作者
Khater, Mostafa [1 ]
Wei, Zhe [1 ]
Xu, Xin [1 ]
Huang, Wei [1 ]
Lokeshwar, Bal L. [2 ]
Lambert, Nevin A. [1 ]
Wu, Guangyu [1 ]
机构
[1] Augusta Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA
[2] Augusta Univ, Georgia Canc Ctr, Augusta, GA USA
基金
美国国家卫生研究院;
关键词
PLASMA-MEMBRANE; COMPLEX TRANSLOCATION; SIGNALING PATHWAY; COUPLED RECEPTORS; ANGIOTENSIN-II; KINASE; ARRESTIN; SUBUNITS; ORGANIZATION; TRAFFICKING;
D O I
10.1016/j.jbc.2021.100325
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Golgi apparatus (GA) is a cellular organelle that plays a critical role in the processing of proteins for secretion. Activation of G protein-coupled receptors at the plasma membrane (PM) induces the translocation of G protein beta gamma dimers to the GA. However, the functional significance of this translocation is largely unknown. Here, we study PM-GA translocation of all 12 G gamma subunits in response to chemokine receptor CXCR4 activation and demonstrate that G gamma 9 is a unique Golgi-translocating G gamma subunit. CRISPR-Cas9-mediated knockout of G gamma 9 abolishes activation of extracellular signal-regulated kinase 1 and 2 (ERK1/2), two members of the mitogen-activated protein kinase family, by CXCR4. We show that chemically induced recruitment to the GA of G beta gamma dimers containing different G gamma subunits activates ERK1/2, whereas recruitment to the PM is ineffective. We also demonstrate that pharmacological inhibition of phosphoinositide 3-kinase. (PI3K gamma) and depletion of its subunits p110 gamma and p101 abrogate ERK1/2 activation by CXCR4 and G beta gamma recruitment to the GA. Knockout of either G gamma 9 or PI3K gamma significantly suppresses prostate cancer PC3 cell migration, invasion, and metastasis. Collectively, our data demonstrate a novel function for G beta gamma translocation to the GA, via activating PI3K gamma heterodimers p110 gamma-p101, to spatiotemporally regulate mitogen-activated protein kinase activation by G protein-coupled receptors and ultimately control tumor progression.
引用
收藏
页数:12
相关论文
共 58 条
[11]   RAS-DEPENDENT ACTIVATION OF MAP KINASE PATHWAY MEDIATED BY G-PROTEIN BETA-GAMMA-SUBUNITS [J].
CRESPO, P ;
XU, NZ ;
SIMONDS, WF ;
GUTKIND, JS .
NATURE, 1994, 369 (6479) :418-420
[12]   ARF1 promotes prostate tumorigenesis via targeting oncogenic MAPK signaling [J].
Davis, Jason E. ;
Xie, Xiayang ;
Guo, Jianhui ;
Huang, Wei ;
Chu, Wen-Ming ;
Huang, Shuang ;
Teng, Yong ;
Wu, Guangyu .
ONCOTARGET, 2016, 7 (26) :39834-39845
[13]   Golgi-disturbing agents [J].
Dinter, A ;
Berger, EG .
HISTOCHEMISTRY AND CELL BIOLOGY, 1998, 109 (5-6) :571-590
[14]   Regulation of α2B-Adrenergic Receptor-mediated Extracellular Signal-regulated Kinase 1/2 (ERK1/2) Activation by ADP-ribosylation Factor 1 [J].
Dong, Chunmin ;
Li, Chunman ;
Wu, Guangyu .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (50) :43361-43369
[15]   ADP-Ribosylation Factors Modulate the Cell Surface Transport of G Protein-Coupled Receptors [J].
Dong, Chunmin ;
Zhang, Xiaoping ;
Zhou, Fuguo ;
Dou, Huijuan ;
Duvernay, Matthew T. ;
Zhang, Ping ;
Wu, Guangyu .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 333 (01) :174-183
[16]   β-Arrestin drives MAP kinase signalling from clathrin-coated structures after GPCR dissociation [J].
Eichel, K. ;
Jullie, D. ;
von Zastrow, M. .
NATURE CELL BIOLOGY, 2016, 18 (03) :303-+
[17]   Subcellular Organization of GPCR Signaling [J].
Eichel, Kelsie ;
von Zastrow, Mark .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2018, 39 (02) :200-208
[18]   Differential G protein subunit expression by prostate cancer cells and their interaction with CXCR5 [J].
El-Haibi, Christelle P. ;
Sharma, Praveen ;
Singh, Rajesh ;
Gupta, Pranav ;
Taub, Dennis D. ;
Singh, Shailesh ;
Lillard, James W., Jr. .
MOLECULAR CANCER, 2013, 12
[19]   The PI3K Pathway in Human Disease [J].
Fruman, David A. ;
Chiu, Honyin ;
Hopkins, Benjamin D. ;
Bagrodia, Shubha ;
Cantley, Lewis C. ;
Abraham, Robert T. .
CELL, 2017, 170 (04) :605-635
[20]  
Gioeli D, 1999, CANCER RES, V59, P279